pharma · Social Anxiety Disorder · Drug Drug Interaction · VTGN
Vistagen Therapeutics
Vistagen Therapeutics clinical programs — 10 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Employees
- 7
- Programs
- 10
- Drugs
- 3
- Patents
- 6
Vistagen Therapeutics projects
10 ClinicalTrials.gov programs sponsored by Vistagen Therapeutics.
Vistagen Therapeutics has 10 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Fasedienol Nasal Spray
Vistagen Therapeutics
Social Anxiety Disorder
1 trial -
Fasedienol Nasal Spray
Vistagen Therapeutics
Social Anxiety Disorder (SAD)
1 trial -
PH94B
Vistagen Therapeutics
Social Anxiety Disorder
1 trial -
PH94B Nasal Spray
Vistagen Therapeutics
Social Anxiety Disorder
2 trials -
AV-101
Vistagen Therapeutics
Parkinson Disease
1 trial -
AV-101
Vistagen Therapeutics
Major Depressive Disorder
1 trial -
Fasedienol Nasal Spray - Placebo Nasal Spray
Vistagen Therapeutics
Social Anxiety Disorder
1 trial -
PH94B
Vistagen Therapeutics
Adjustment Disorder With Anxious Mood
1 trial -
Placebo
Vistagen Therapeutics
Healthy
1 trial -
AV-101
Vistagen Therapeutics
Drug Drug Interaction
1 trial
Frequently asked questions
How many clinical projects does Vistagen Therapeutics have?
10 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.